News-Medical.Net on MSN
Simple fruit granola intervention shows promising cardio-renal signals in CKD patients
A single-arm intervention study in Japanese adults with moderate chronic kidney disease found that replacing breakfast with ...
MediBeacon ® TGFR™ System is a first-in-kind product for point of care kidney function assessment Centers of Excellence commercialization in ...
In a new study, researchers have discovered a connection between inflammation in the areas of interstitial fibrosis and tubular atrophy (IFTA).
I have suffered from high blood pressure since I was a young man in my early 20s. I recently turned 70 years old. My blood pressure has been controlled by various medications. Most recently, I have ...
Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.
General Dynamics Information Technology (GDIT), a business unit of General Dynamics , announced today it was awarded a $285 million contract by the Commonwealth of Virginia to strengthen its ...
The phase 2 BESTOW trial evaluated the safety and efficacy of tegoprubart vs tacrolimus in the prevention of rejection in patients undergoing kidney transplantation.
Important Safety Information Indication Elfabrio ® (pegunigalsidase alfa for injection) is an enzyme replacement therapy indicated for the longterm treatment of adult patients with a confirmed ...
Elfabrio (R) (pegunigalsidase alfa for injection) is an enzyme replacement therapy indicated for the longterm treatment of adult patients with a confirmed diagnosis of Fabry disease (deficiency of ...
Office and ambulatory BP improved, with minimal side effects, although some say edema needs to be watched carefully.
3don MSN
Reverse kidney damage naturally: Top foods and daily habits to cut inflammation and boost metabolism
Kidney damage develops silently through chronic inflammation and daily stress. Doctors say early action matters. Hydrating ...
This year’s most-read articles on CKD highlighted research and insights on drug approvals, guidelines, and value-based care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results